Over time, quadruple therapy with ARNI, SGLT-2 inhibitors, beta blockers, and mineral receptor antagonists has repeatedly been shown to be effective in significantly reducing mortality and HF readmissions108,109. This evidence concerns the gene SLC5A2 and hydrops fetalis.